CD274 and prostate cancer: TMB levels were positively correlated with microsatellite instability (MSI) and PD-L1 expression (Figures 10F, G), suggesting that increased mutational load may contribute to enhanced immunogenicity and immune checkpoint activation in prostate cancer.